Insider · CIK 0001304815

IGUCHI KIMI

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001304815

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-05	Sage Therapeutics, Inc.F Tax Payment	CFO & Treasurer	FTax Payment	−3,636 sh	$8.96	−$32.6K	81,405
2024-08-05	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+13.5K sh	—	—	85,041
2024-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+22.5K sh	—	—	22,500
2024-02-13	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+11.3K sh	—	—	81,679
2024-01-02	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,642 sh	$1.36	+$2,233.12	70,429
2024-01-02	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−1,642 sh	—	—	0
2023-11-28	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+3,500 sh	—	—	69,730
2023-11-28	Sage Therapeutics, Inc.F Tax Payment	CFO & Treasurer	FTax Payment	−943 sh	$19.27	−$18.2K	68,787
2023-03-15	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+3,000 sh	$1.36	+$4,080	65,560
2023-03-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−3,000 sh	—	—	1,642
2023-02-23	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+250 sh	$1.36	+$340	62,560
2023-02-23	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−250 sh	—	—	4,642
2023-02-21	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−750 sh	—	—	4,892
2023-02-21	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+750 sh	$1.36	+$1,020	62,310
2023-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+16.7K sh	—	—	16,720
2023-02-03	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+2,850 sh	—	—	62,474
2023-02-03	Sage Therapeutics, Inc.F Tax Payment	CFO & Treasurer	FTax Payment	−914 sh	$44.16	−$40.4K	61,560
2023-01-09	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,600 sh	$1.36	+$2,176	59,624
2023-01-09	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−1,600 sh	—	—	5,642
2023-01-04	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−1,800 sh	—	—	7,242
2023-01-04	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,800 sh	$1.36	+$2,448	58,024
2022-02-17	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+4,500 sh	$1.36	+$6,120	55,600
2022-02-17	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−4,500 sh	—	—	9,042
2022-02-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+15.2K sh	—	—	15,200
2021-11-23	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−495 sh	—	—	0
2021-11-23	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−505 sh	—	—	13,542
2021-11-23	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,000 sh	$1.36	+$1,360	51,100
2021-11-22	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+2,500 sh	$1.36	+$3,400	50,100
2021-11-22	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−2,500 sh	—	—	495
2021-10-19	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+3,800 sh	—	—	48,624
2021-10-19	Sage Therapeutics, Inc.F Tax Payment	CFO & Treasurer	FTax Payment	−1,024 sh	$40.29	−$41.3K	47,600
2021-06-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−2,000 sh	—	—	14,047
2021-06-16	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+2,000 sh	$1.36	+$2,720	44,533
2021-06-15	Sage Therapeutics, Inc.A Award	CFO & Treasurer	AAward	+3,500 sh	—	—	43,355
2021-06-15	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+3,000 sh	$1.36	+$4,080	39,855
2021-06-15	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−3,000 sh	—	—	16,047
2021-06-15	Sage Therapeutics, Inc.F Tax Payment	CFO & Treasurer	FTax Payment	−822 sh	$58.80	−$48.3K	42,533
2021-04-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−948 sh	—	—	0
2021-04-13	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,500 sh	$1.36	+$2,040	36,855
2021-04-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−552 sh	—	—	2,995
2021-02-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+19K sh	—	—	19,000
2021-01-05	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+1,750 sh	$1.36	+$2,380	35,355
2021-01-05	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−1,750 sh	—	—	948
2020-04-30	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−4,000 sh	—	—	2,698
2020-04-30	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+4,000 sh	$1.36	+$5,440	33,261
2020-04-28	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+9,450 sh	—	—	9,450
2020-02-12	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	CFO & Treasurer	AAward	+17.5K sh	—	—	17,500
2019-12-10	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+500 sh	$1.36	+$680	29,261
2019-12-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	−500 sh	—	—	3,547
2019-12-09	Sage Therapeutics, Inc.M Exercise/Conversion	CFO & Treasurer	MExercise/Conversion	+15K sh	$1.36	+$20.4K	28,761

Recent filings

Accepted (ET)
Aug 74
IGUCHI KIMI0001562180-24-006088
SEC(opens sec.gov)
Feb 154
IGUCHI KIMI0001562180-24-001333
SEC(opens sec.gov)
Jan 44
IGUCHI KIMI0001562180-24-000222
SEC(opens sec.gov)
Nov 304
IGUCHI KIMI0001562180-23-007979
SEC(opens sec.gov)
Mar 174
IGUCHI KIMI0001562180-23-002907
SEC(opens sec.gov)
Feb 234
IGUCHI KIMI0001562180-23-001787
SEC(opens sec.gov)
Feb 154
IGUCHI KIMI0001562180-23-001421
SEC(opens sec.gov)
Feb 74
IGUCHI KIMI0001562180-23-001081
SEC(opens sec.gov)
Jan 114
IGUCHI KIMI0001562180-23-000354
SEC(opens sec.gov)
Jan 54
IGUCHI KIMI0001562180-23-000237
SEC(opens sec.gov)

Companies

Address

C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET

CAMBRIDGE, MA, 02142